Listen
Active substance (DCI)
- axicabtagene ciloleucel
history (11)
-
4/4/24
YESCARTA (axicabtagene ciloleucel) - Lymphome folliculaire
-
2/16/23
YESCARTA (axicabtagene ciloleucel) - Lymphome LDGCB - LHGCB
-
9/6/23
YESCARTA (axicabtagene ciloleucel) - Large B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMLBCL)
CAV : -
7/20/23
YESCARTA (axicabtagene ciloleucel) - Lymphome diffus à grandes cellules B
-
4/6/23
YESCARTA (axicabtagene ciloleucel) - Lymphome folliculaire
-
2/15/23YESCARTA (axicabtagène ciloleucel) - Lymphome diffus à grandes cellules B (LDGCB) et lymphome de haut grade à cellules B (LHGCB)
CAV :
-
7/13/22
YESCARTA (axicabtagene ciloleucel) - Lymphome diffus à grandes cellules B
-
1/18/23
YESCARTA (axicabtagène ciloleucel) - Lymphome folliculaire
CAV : -
4/14/22
YESCARTA (axicabtagene ciloleucel) - Lymphome folliculaire
-
3/24/21
YESCARTA (axicabtagene ciloleucel)
CAV : -
12/5/18
YESCARTA (axicabtagene ciloleucel), CAR T anti-CD19
CAV :
